<DOC>
	<DOCNO>NCT00789126</DOCNO>
	<brief_summary>Study evaluate safety tolerability single ascending dos multiple ascend dos VX-509 administer healthy male female subject</brief_summary>
	<brief_title>Single Multiple Dose Escalation Study VX-509 Healthy Subjects</brief_title>
	<detailed_description>Part A study evaluate safety tolerability , PK , PD single ascend dos VX-509 . Part B evaluate safety tolerability , PK , PD multiple ascend dos VX-509 administer 14 day . A total 72 subject enrol : 36 subject Part A 36 subject Part B .</detailed_description>
	<criteria>Healthy , nonsmoking male healthy , nonsmoking , nonpregnant female Able comply study procedure Male subject must agree use 2 highly effective method contraception Female subject must document nonchildbearing potential must agree use 2 highly effective method contraception No clinically significant abnormal result physical examination clinically significant range laboratory result History significant illness Illness within 5 day Day 1 Regular treatment medication Any type tobacco nicotine use History drug alcohol abuse addiction within 2 year Screening visit Positive tuberculin skin test Screening Female subject lactate plan become pregnant study period within 90 day last dose study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>